<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="143019">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02031484</url>
  </required_header>
  <id_info>
    <org_study_id>Zio study</org_study_id>
    <nct_id>NCT02031484</nct_id>
  </id_info>
  <brief_title>Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial</brief_title>
  <official_title>Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bardy Diagnostics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bardy Diagnostics, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to compare the new Carnation patch monitoring system with the Zio
      patch, which represents the current standard for continuous recording of the ECG over
      extended periods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this research is to confirm the clinical value of a new P-wave sensitive
      recording vector combined with an easy-to-use long-term cardiac rhythm monitoring patch
      system, the CarnationTM Ambulatory Monitoring (CAM) System.  The P-wave is a critical aspect
      of the electrocardiogram and a key finding for proper arrhythmia diagnosis.  The CAM system
      is optimized for both ease of use and for maximum P-wave clarity for arrhythmia diagnosis.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>ECG signal quality</measure>
    <time_frame>14 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>ECG signal quality = scoring the ability of each system to record electrical activity from the atrium (P-waves).  The Physician Event Committee will independently score the P-waves from all recordings, using the following scale: Excellent, Good, Fair, Poor, Non-existent.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device comfort</measure>
    <time_frame>14 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Secondary outcome measures will include Human Factors performance of the 2 systems, which will be scored and compared in the following areas and duration of patch adherence: skin irritation, comfort, contact and stability.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Syncope</condition>
  <condition>Presyncope</condition>
  <condition>Palpitations</condition>
  <condition>Atrial Fibrillation</condition>
  <condition>Supraventricular Tachycardia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in Chicago, Charlotte, and Iowa under the care of a physician for symptoms listed
        in the inclusion criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Syncope of uncertain etiology or

          -  Pre-syncope of uncertain etiology or

          -  Palpitations of uncertain etiology or

          -  Management of known AF/SVT patients

        Exclusion Criteria:

          -  Any dermatitis or infected skin over the sternum (Carnation patch) or left upper
             anterior thorax (Zio patch).

          -  A sternal or thoracic incision that extends under the patch within 3 months from the
             date of enrollment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Kremers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mid Carolina Cardiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin Burke, MD</last_name>
      <phone>773-702-5988</phone>
      <email>mburke@medicine.bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Martin Burke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brian Olshansky, MD</last_name>
      <phone>319-331-0342</phone>
      <email>brian-olshansky@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Brian Olshansky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mid Carolina Cardiology</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mark Kremers, MD</last_name>
      <phone>704-343-9800</phone>
      <email>mskremers@novanthealth.org</email>
    </contact>
    <investigator>
      <last_name>Mark Kremers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eastside Cardiology</name>
      <address>
        <city>Kirkland</city>
        <state>Washington</state>
        <zip>98034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mark Vossler, MD</last_name>
      <phone>425-899-0555</phone>
      <email>vosslerm1@mac.com</email>
    </contact>
    <investigator>
      <last_name>Mark Vossler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>January 8, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Syncope</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Supraventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
